Free Expedited Rx ShippingFree ConsultationBoard-Certified Care
Compounded PT-141 injection vial with green cap and gold band on a transparent background

Women's Health

PT-141

Desire that starts where it should, in the brain.

PT-141 (bremelanotide) is a prescription peptide that works through the central nervous system to support sexual desire and arousal. It does not work through vascular or hormonal mechanisms but by activating melanocortin receptors in the brain.

Starting at $226.99/month

10% off your first month. Reflects the 1-month intro price.

Get Started

Available in all 50 states.

Free telehealth consultation. Pay only if a provider approves your treatment plan.

A licensed provider determines the right dose for you.

HSA and FSA accepted.

Compounded in a licensed pharmacy.

Why patients choose Medura.

Real providers, not AI

Every treatment plan is reviewed by a board-certified provider who has time to know your full medical history, not just your symptoms.

Transparent pricing, no surprises

See the exact price before you start. No hidden fees, no surprise charges at checkout, no auto-escalating "optimization" costs.

Made in FDA-registered U.S. facilities

Compounded and quality-tested domestically. Discreet packaging. We cover shipping on all plans.

Support that actually listens

Your care team stays with you long after the first shipment. Real check-ins, dose adjustments based on how you actually feel, and honest answers to real questions.

What this is

PT-141 (bremelanotide) is a prescription peptide that works through the central nervous system to support sexual desire and arousal. It does not work through vascular or hormonal mechanisms but by activating melanocortin receptors in the brain.

At Medura, PT-141 is available as a subcutaneous injection for women experiencing low sexual desire. A licensed provider reviews your health history, determines whether you are an appropriate candidate, and builds a plan that fits your life.

What to expect

Your treatment timeline, so you know what's coming and when to expect real changes.

  1. 1

    Start with a consultation

    A licensed provider reviews your intake and health history to decide whether PT-141 is appropriate for you and what dose is right.

  2. 2

    Used as needed

    PT-141 is typically administered subcutaneously 45 minutes to an hour before anticipated activity. Your provider gives you clear instructions for use.

  3. 3

    What to expect

    Many patients report a noticeable effect within the first use at the right dose. Your provider adjusts the plan based on your response.

How PT-141 works differently

Most treatments for sexual dysfunction focus on blood flow or hormone levels. PT-141 takes a different path, working directly at the level of the brain to support desire and arousal through melanocortin receptor activity.

  • Central nervous system mechanism

    PT-141 activates MC3R and MC4R melanocortin receptors in the hypothalamus, a region of the brain involved in regulating sexual motivation. This is how it supports desire at the source rather than addressing a downstream symptom.

  • On-demand use that fits your life

    PT-141 is administered subcutaneously about 45 minutes before anticipated activity. There is no daily pill routine. You use it when you want to, guided by your provider on the right dose and timing.

  • Designed for women with HSDD

    PT-141 is specifically studied in women with hypoactive sexual desire disorder. A licensed provider determines whether it is appropriate for you based on your full health history, not a checklist.

A couple sitting together on a sofa in a bright living room, relaxed and affectionate in natural afternoon light

Safety and eligibility

This treatment is prescription-only. Your eligibility will be determined during your free consultation with a provider based on your full medical history, current medications, and health goals. Nothing on this page guarantees approval.

Generally appropriate for:

  • Adult women experiencing low sexual desire or hypoactive sexual desire disorder
  • Those who have not responded to hormonal interventions
  • Patients without significant cardiovascular conditions

Generally not appropriate if:

  • Patients with uncontrolled hypertension
  • Those taking certain medications that interact with melanocortin agonists
  • Pregnant or breastfeeding individuals
  • Patients with a history of cardiovascular disease without provider clearance

Common side effects:

Nausea (most common, typically temporary)

Flushing or warmth in the face and neck

Headache

Mild increase in blood pressure (monitored during consultation)

Injection site discomfort

Individual results vary. This is not a complete list of potential side effects. Your provider will review all risks during your consultation.

Questions, answered

You might also explore

The version of you that you miss is still in there.

Start with a free consultation. No pressure, no commitment, just a conversation about what is possible.